Table 1.
Experimental data on EP and structural properties of the BZ.
Study | Species | Stage | Region | EP prop. | Structural prop. |
---|---|---|---|---|---|
Lue and Boyden, 1992 | Dog | 5 d | Epi BZ | ↓Ito ↑APD100 | – |
↓APA | |||||
Pu and Boyden, 1997 | Dog | 5 d | Epi BZ | ↓INa | – |
Jiang et al., 2000 | Dog | 5 d | Epi BZ | ↓IKr ↓IKs | – |
Dun et al., 2004 | Dog | 5–14 d | Epi BZ | ↓Ito ↓ICaL | – |
8 w | ↓ICaL | ||||
Baba et al., 2005 | Dog | 5 d | Epi BZ | ↓ICaL ↓INa | – |
↓APD90 | |||||
Cabo et al., 2006 | Dog | 4–5 d | Epi BZ | – | ↓GTrans |
GJ lat ↓CV | |||||
Ursell et al., 1985 | Dog | 5 d | Epi BZ | ↓MUV ↓APD90 | nCV |
↓ APA nEG | |||||
2 w | ↓APD90 | Fibrosis | |||
8 w | nAPD nMUV | ↓CV iso | |||
nAPA | Disarray | ||||
Fibrosis | |||||
Gardner et al., 1985 | Dog | 5 d | Epi BZ | ↓MUV ↓APD90 | nCV |
↓APA nEG | |||||
2 w | ↓APD90 fEG | Fibrosis | |||
8 w | nAPD nMUV | ↓CV iso | |||
nAPA fEG | Disarray | ||||
Fibrosis | |||||
Spear et al., 1983 | Dog | 3–5 d | Epi BZ | ↓MUV ↓APD30 | – |
↓APA nAPD100 | |||||
8–15 d | ↓APD30 nAPD100 | ||||
Luke and Saffitz, 1991 | Dog | 3–10 w | Epi BZ | – | ↓GJ density |
Fibrosis | |||||
Peters et al., 1997 | Dog | 4 d | Epi BZ | – | GJ lat |
Yao et al., 2003 | Dog | 5 d | Epi BZ | – | ↓GTrans |
Pinto et al., 1997 | Cat | 2–4 m | EndoL BZ | ↓ICaL | – |
Kimura et al., 1986 | Cat | 2–6 m | EndoL BZ | ↓APD90 ↓APA | – |
EndoC BZ | ↑APD90 | – | |||
Wong et al., 1982 | Cat | 2–7 m | EndoL BZ | ↓APD90 | – |
EndoC BZ | ↑APD90 | – | |||
Myerburg et al., 1982 | Cat | 2–4 m | EndoC BZ | ↑APD90 | Fibrosis |
Kimura et al., 1988 | Cat | 2–4 m | EndoC BZ | nAPD50 nAPD90 | – |
Pop et al., 2012 | Pig | 4 w | Epi BZ | ↓APD ↓MUV | ↓CV Disarray |
↓APA | |||||
Denisko et al., 2017 | Pig | 5 w | BZ | nAPD | – |
Mills et al., 2005 | Mouse | 7 d | Epi BZ | nAPD90 | ↓CVTrans |
Fibrosis | |||||
Rutherford, 2013 | Mouse | 14 d | BZ | – | ↓CVTrans |
Fibrosis | |||||
Disarray | |||||
Weigand et al., 2016 | Mouse | 6 w | Epi BZ | nAPD90 | – |
Chou et al., 2007 | Rabbit | 7 d | BZ | ↓APD80 | – |
Lee et al., 2013 | Rabbit | 5 w | BZ | ↑IKAS ↓APD80 | – |
Litwin and Bridge, 1971 | Rabbit | 8 w | BZ | ↓ICaL ↑APD90 | – |
Walker et al., 2007 | Rabbit | 8 w | BZ | Abnormal AP | ↓CV |
Spear et al., 1979 | Human | 1 m+ | EndoC BZ | ↑APD90 | Fibrosis |
Dangman et al., 1982 | Human | 12 m+ | EndoL BZ | nAPD90 | – |
EndoC BZ | ↑APD90 | – | |||
Smith et al., 1991 | Human | – | EndoC BZ | – | GJ lat Fibrosis |
Disarray | |||||
Kostin et al., 2003 | Human | – | BZ | – | GJ lat Fibrosis |
Disarray | |||||
Bakker et al., 1988 | Human | 16 d+ | EndoC BZ | fEG | ↓CVTrans |
Disarray | |||||
Fibrosis | |||||
Pogwizd et al., 1992 | Human | 4 m+ | BZ | fEG | ↓CVTrans |
Disarray | |||||
Fibrosis |
Disease stage is presented in days (d), weeks (w), or months (m). In most studies, a distinction between epicardium (Epi) BZ, endocardial-central (EndoC) BZ, and endocardial-lateral (EndoL) BZ was made. EP properties (prop.) include action potential duration (APD), maximum upstroke velocity (MUV), action potential amplitude (APA), fast sodium current (INa), L-type calcium current (ICaL), rapid and slow rectifying potassium currents (IKr and IKs, respectively), the transient potassium current (Ito), the Apamin-sensitive potassium current (IKAS) and electrograms (EG), normal (nEG) or fractionated (fEG). Structural properties include, gap junction (GJ) transverse conductance (Gtrans) and lateralization (lat), conduction velocity (CV), and the presence of fibrosis or (fiber) disarray. Arrows indicate increased (↑) or decreased (↓) quantities relative to normal myocardium, whereas “n” indicates normal or unchanged characteristics.